<DOC>
	<DOCNO>NCT00563095</DOCNO>
	<brief_summary>Primary : To compare efficacy TACE TAIE . Secondary : To compare side effect TACE TAIE . The outcome measurement include survival benefit tumour regression induce two therapy .</brief_summary>
	<brief_title>A Comparative Study Efficacy Transcatheter Arterial Chemoembolization ( TACE ) Transcatheter Arterial Pegylated Interferon Embolization ( TAIE ) Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Confirmed hepatocellular carcinoma suitable surgery Portal vein thrombosis Severe arteriovenous shunt Bilirubin level &gt; 50 umol/mL Prothrombin time &gt; 5 second</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
</DOC>